Last: | $177.59 |
---|---|
Change Percent: | -0.01% |
Open: | $179.15 |
Close: | $177.61 |
High: | $179.43 |
Low: | $177.33 |
Volume: | 547,121 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$177.59 | $179.15 | $177.61 | $179.43 | $177.33 | 547,121 | 04-19-2024 |
$177.61 | $177.4 | $177.61 | $179.8 | $176.33 | 1,582,460 | 04-18-2024 |
$173.83 | $182 | $173.83 | $183.4 | $172.19 | 3,005,122 | 04-17-2024 |
$184.86 | $184.46 | $184.86 | $186.715 | $183.37 | 411,889 | 04-16-2024 |
$185.09 | $187.95 | $185.09 | $189.29 | $184.78 | 605,411 | 04-15-2024 |
$185.86 | $188.62 | $185.86 | $189.41 | $184.39 | 659,893 | 04-12-2024 |
$189.51 | $195.14 | $189.51 | $195.14 | $189.4 | 696,180 | 04-11-2024 |
$193.8 | $190.72 | $193.8 | $194.62 | $190.5175 | 915,277 | 04-10-2024 |
$194.27 | $189 | $194.27 | $194.38 | $187.98 | 988,292 | 04-09-2024 |
$187.76 | $188.61 | $187.76 | $188.965 | $187.5 | 773,962 | 04-08-2024 |
$188.76 | $185.02 | $188.76 | $189.56 | $185.02 | 749,100 | 04-05-2024 |
$185 | $187.6 | $185 | $188.15 | $184.84 | 872,947 | 04-04-2024 |
$186.04 | $185.99 | $186.04 | $189.04 | $185.39 | 1,456,194 | 04-03-2024 |
$184.36 | $187.59 | $184.36 | $188.285 | $182.29 | 984,772 | 04-02-2024 |
$189.32 | $198.31 | $189.32 | $198.31 | $189.24 | 1,532,670 | 04-01-2024 |
$198.03 | $197.14 | $198.03 | $198.535 | $196.47 | 622,676 | 03-29-2024 |
$198.03 | $197.14 | $198.03 | $198.535 | $196.47 | 622,676 | 03-28-2024 |
$196.33 | $195.49 | $196.33 | $196.75 | $194.21 | 567,412 | 03-27-2024 |
$194.18 | $193.5 | $194.18 | $195.66 | $192.99 | 1,108,903 | 03-26-2024 |
$193.31 | $192.5 | $193.31 | $194.59 | $191.82 | 1,836,891 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
2024-04-17 18:51:53 ET For both the biotech and pharmaceutical industries, what happens in the laboratory is critical to success (or failure, on the flip side). Some good news from a clinical trial conducted by Eli Lilly (NYSE: LLY) boosted the share price of the pharmaceutical ...
2024-04-10 08:00:07 ET Craig Wong-Pan from RBC Capital issued a price target of $187.00 for RMD on 2024-04-10 07:09:00. The adjusted price target was set to $187.00. At the time of the announcement, RMD was trading at $194.27. The overall price target consensus is at $21...
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Uber Technologies, Inc. (NYSE: UBER). "I think Uber is ...